Abstract
Significantly reduced morbidity and mortality is needed before intestinal transplantation will be applicable in most patients with intestinal failure who are on long-term total parenteral nutrition (TPN). However, transplantation does play a role if TPN fails, with failure defined by Medicare as liver failure, frequent line sepsis, major central vein thrombosis, or recurrent dehydration. Of these complications, the relationship between liver failure and subsequent death in high-risk subgroups of long-term TPN patients has been shown clearly. Patients with less than 100 cm of postduodenal small bowel, an end-jejunostomy, no ileocecal valve or cecum, or persistently elevated liver function levels are at high risk for end-stage liver disease (ESLD). Early referral to experienced centers is suggested in these circumstances. High-risk patients may also take part in clinical trials of promising therapies to increase intestinal adaptation and prevent liver failure. Living donors should be considered for transplant candidates to minimize waiting time and optimize HLA matching. ESLD patients need a liver-intestine transplant. Because their waiting-list mortality is very high, their status on the liver waiting list should be elevated if possible. High incidence of early death from sepsis is reported after intestinal transplant, even at experienced centers. Aggressive measures should be taken if uncontrolled sepsis occurs, including discontinuing immunosuppression and removing the graft. Further research is needed in intestinal immunology and in development of strategies to decrease the need for aggressive immunosuppression in these transplant recipents. The ultimate role of intestinal transplantation will be determined by its capacity to show superiority, both in effectiveness and safety, to long-term TPN.
Article PDF
Similar content being viewed by others
References and Recommended Reading
Grant D: Intestinal transplantation: 1997 report of the international registry. Transplantation 1999, 67:1061–1064. Also available at www.lhsc.on.ca/itr Summary of the world experience with intestinal transplantation, including complications. Website provides updates.
2000 Annual Report of the US Scientific Registry of Transplant Recipients and the Organ Procurement and Transplantation Network. Transplant Data 1990–1999. Rockville, MD and Richmond, VA: US Department of Health and Human Services, Health Resources and Services Administration, Office of Special Programs, Division of Transplantation and United Network of Organ Sharing; 2000. Complete analysis of graft and patient survivals in US intestinal transplant recipients. Also valuable data on donors and waiting lists.
Howard L, Ament M, Fleming CR, et al.: Current use and clinical outcome of home parenteral and enteral nutrition therapies in the United States. Gastroenterology 1995, 109:355–365.
Quigley EM, Marsh MN, Shaffer JL, Markin RS: Hepatobiliary complications of total parenteral nutrition. Gastroenterology 1993, 104:286–301.
Cavicchi M, Beau P, Crenn P, et al.: Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med 2000, 132:525–532. Provides an important analysis of factors influencing liver disease development in a comprehensive population of long-term TPN patients.
Kelly DA: Liver complications of pediatric parenteral nutrition: epidemiology. Nutrition 1998, 14:153–157.
Chan S, McCowen KC, Bistrian BR, et al.: Incidence, prognosis, and etiology of end-stage liver disease in patients receiving home parenteral nutrition. Surgery 1999, 126:28–34.
Buchmiller CE, Kleiman-Wexler RL, Ephgrave KS, et al.: Liver dysfunction and energy source: results of a randomized clinical trial. JPEN J Parenter Enteral Nutr 1993, 17:301–306.
Grant JP, Cox CE, Kleinman LM, et al.: Serum hepatic enzyme and bilirubin elevations during parenteral nutrition. Surg Gynecol Obstet 1977, 145:573–580.
Buchman AL, Dubin MD, Moukarzel AA, et al.: Choline deficiency: a cause for hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation. Hepatology 1995, 22:1399–1403.
Messing B, Crenn P, Beau P, et al.: Long-term survival and parenteral nutrition dependence in adult patients with short bowel syndrome. Gastroenterology 1999, 117:1043–1050. This report provides an important evaluation of risk factors predictive for permanent TPN dependence and mortality in a comprehensive population of long-term TPN patients.
Horslen SP, Kaufman SS, Sudan DL, et al.: Isolated liver transplantation in infants with total parenteral nutrition-associated end-stage liver disease. Transplant Proc 2000, 32:1241.
Sudan DL, Kaufman SS, Shaw BW, et al.: Isolated intestinal transplantation for intestinal failure. Am J Gastroenterol 2000, 95:1506–1515.
Moukarzel AA, Haddad I, Ament ME, et al.: 230 patient years of experience with home long-term parenteral nutrition in childhood: natural history and life of central venous catheters. J Pediatr Surg 1994, 29:1323–1327.
Pierro A, Van Saene HKF, Donnell SC, et al.: Microbial translocation in neonates and infants receiving long-term parenteral nutrition. Arch Surg 1996, 131:176–179.
Zaleski GX, Funaki B, Lorenz JM, et al.: Experience with tunneled femoral dialysis catheters. Am J Roentgenol 1999, 172:493–496.
Beers TR, Burnes J, Fleming CR: Superior vena caval obstruction in patients with gut failure receiving home parenteral nutrition. J Parenter Enteral Nutr 1990, 14:474–479.
Dollery CM, Sullivan ID, Bauraind O, et al.: Thrombosis and embolism in long-term central venous access for parenteral nutrition. Lancet 1994, 344:1043.
Stine KC, Friedman HS, Kurtzberg J, et al.: Pulmonary septic emboli mimicking metastatic rhabdomyosarcoma. J Pediatr Surg 1989, 24:491–493.
Hayden L, Stewart GR, Johnson DC, Fisher MM: Transthoracic right atrial cannulation for total parenteral nutrition: case report. Anaesth Intensive Care 1981, 9:53–57.
Book WM, Raviele AA, Vincent RN: Transhepatic vascular access in pediatric cardiology patients with occlusion of traditional central venous sites. J Invasive Cardiol 1999, 11:341–344.
Robertson LJ, Jaques PF, Mauro MA, et al.: Percutaneous inferior vena cava placement of tunneled silastic catheters for prolonged vascular access in infants. J Pediatr Surg 1990, 25:596–598.
Galandiuk S, O’Neill M, McDonald P, et al.: A century of home parenteral nutrition for Crohn’s disease. Am J Surg 1990, 159:540–544.
Buchman AL, Moukarzel A, Ament ME, et al.: Serious renal impairment is associated with long-term parenteral nutrition. JPEN J Parenter Enteral Nutr 1993, 17:438–444.
Idoate MA, Martinez AJ, Bueno J, et al.: The neuropathology of intestinal failure and small bowel transplantation. Acta Neuropathol 1999, 97:502–508.
Jeppesen PB, Hartmann B, Thulesen J, et al.: Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon. Gastroenterology 2001, 120:806–815.
Thompson JS, Langnas AN: Surgical approaches to improving intestinal function in the short-bowel syndrome. Arch Surg 1999, 134:706–709. Summary of surgical alternatives to intestinal transplantation.
Royall D, Wolever BM, Jeejeebhoy KN: Evidence for colonic conservation of malabsorbed carbohydrate in short bowel syndrome. Am J Gastroenterol 1992, 87:751–756.
Bueno J, Guitterrez J, Mazariegos GV, Abu-Elmagd K, et al.: Analysis of patients with longitudinal intestinal lengthening procedure referred for intestinal transplantation. J Pediatr Surg 2001, 36:178–183.
deVille de Goyet J, Mitchell A, Mayer AD, et al.: En block combined reduced-liver and small bowel transplants: from large donors to small children. Transplantation 2000, 69:555–559. This report introduces an important technique to make transplantation possible despite significant donor-recipient size discrepancy.
Manez R, Kusne S, Green M, et al.: Incidence and risk factors associated with the development of cytomegalovirus disease after intestinal transplantation. Transplantation 1995, 59:1010–1014.
Tzakis AG, Todo S, Reyes J, et al.: Intestinal transplantation in children under FK506 immunosuppression. J Pediatr Surg 1993, 28:1040–1043.
Pinna AD, Weppler D, Nery JR, et al.: Induction therapy for clinical intestinal transplantation: comparison of four different regimens. Transplant Proc 2000, 32:1193–1194.
Pappas PA, Weppler D, Pinna AD, et al.: Sirolimus in pediatric gastrointestinal transplantation: the use of sirolimus for pediatric transplant patients with tacrolimus related cardiomyopathy. Pediatr Transplant 2000, 44:45–49.
Abu-Elmagd K, Fung J, McGhee W, et al.: The efficacy of daclizumab for intestinal transplantation: preliminary report. Transplant Proc 2000, 32:1195–1196.
Abu-Elmagd K, Reyes J, Todo S, et al.: Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg 1998, 186:512–525. Review of a single-center experience with simultaneous bone marrow administration at the time of intestinal transplantation.
Fortner JG, Sichuk G, Litwin SD, Beattie EJ: Immunological responses to an intestinal allograft with HLA identical donor-recipient. Transplantation 1972, 14:531–535.
Cicalese L, Sileri P, Asolati M, et al.: Low infectious complications in segmental living related small bowel transplantation in adults. Clin Transplant 2000, 14:567–571.
Fishbein TM, Bodian CA, Miller CM: National sharing of cadaveric isolated intestinal allografts for human transplantation: a feasibility study. Transplantation 2000, 69:859–863.
Kato T, O’Brien CB, Nishida S, et al.: The first case of the use of a zoom videoendoscope for the evaluation of small bowel graft mucosa in a human after intestinal transplantation. Gastrointest Endosc 1999, 50:257–261.
Finn L, Reyes J, Bueno J, Yunis E: Epstein-Barr virus infections in children after transplantation of the small intestine. Am J Surg Pathol 1998, 22:299–309.
Green M, Bueno J, Rowe D, et al.: Predictive negative value of persistent low Epstein-Barr virus viral load after intestinal transplantation in children. Transplantation 2000, 70:593–596.
Niv Y, Mor E, Tzakis A: Small bowel transplantation: a clinical review. Am J Gastroenterol 1999, 94:3126–3130.
Langnas AN, Sudan DL, Kaufman S, et al.: Intestinal transplantation: a single center experience. Transplant Proc 2000, 32:1228.
Smith CE: Quality of life in long-term total parenteral nutrition patients and their family caregivers. JPEN J Parenter Enteral Nutr 1993, 17:501–506.
Jeppesen PB, Langholz E, Mortenson PB: Quality of life in patients receiving home parenteral nutrition. Gut 1999, 44:844–852. Thorough evaluation of a comprehensive population of HPN patients.
DiMartini A, Rovera GM, Graham TO, et al.: Quality of life after small intestinal transplantation and among home parenteral nutrition patients. JPEN J Parenter Enteral Nutr 1998, 22:357–362.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jonathan Paul, F. The role of intestinal transplantation in the Management of intestinal failure. Curr Gastroenterol Rep 3, 334–342 (2001). https://doi.org/10.1007/s11894-001-0057-9
Issue Date:
DOI: https://doi.org/10.1007/s11894-001-0057-9